Mechanisms underlying treatment failure of antileishmanial therapy are unclear. Here the authors provide transcriptome data of innate immune cells from cutaneous leishmaniasis patients undergoing treatment and find that a heightened type-I interferon response is associated with treatment failure.
- María Adelaida Gómez
- Ashton Trey Belew
- Najib M. El-Sayed
